Skip to main content

Table 4 Predictors of intestinal microsporidiosis among HIV/AIDS patients receiving ART in the clinic of NACP at Al-Jomhori Educational Hospital in Sana’a, Yemen (2019–2020)

From: Intestinal microsporidiosis among HIV/AIDS patients receiving antiretroviral therapy in Sana’a city, Yemen: first report on prevalence and predictors

Variable

N

Intestinal microsporidiosis

P-value

n (%)

OR (95% CI)

CD4 cell count (/µl)

    

 < 200

90

23 (25.6)

2.7 (1.5–5.0)

0.001

 ≥ 200

306

34 (11.1)

Reference

Source of drinking water

 Bottled

150

17 (11.3)

Reference

0.238

 Unbottled

252

40 (15.9)

1.5 (0.8–2.7)

Bathing and/or swimming outdoors

 Yes

93

12 (12.9)

0.9 (0.4–1.7)

0.738

 No

309

45 (14.6)

Reference

Contact with soil

 Yes

287

46 (16.0)

2.4 (0.9–6.2)

0.083

 No

67

5 (7.5)

Reference

Washing hands after contact with soil

 Yes

133

11 (8.3)

Reference

0.002

 No

155

34 (21.9)

3.1 (1.5–6.4)

Washing hands before eating

 Yes

307

30 (9.8)

Reference

 < 0.001

 No

95

27 (28.4)

3.7 (2.0–6.6)

Eating unwashed raw produce

 Yes

199

37 (18.6)

2.1 (1.2–3.7)

0.015

 No

201

20 (10.0)

Reference

Presence of domestic animals in the house

 Yes

178

22 (12.4)

0.8 (0.4–1.4)

0.390

 No

224

35 (15.6)

Reference

Presence of indoor latrines

 Yes

385

46 (11.9)

Reference

 < 0.001

 No

17

11 (64.7)

13.5 (4.8–38.3)

Indiscriminate defecation

 Yes

162

24 (14.8)

1.1 (0.6–2.0)

0.877

 No

182

25 (13.7)

Reference

  1. N number examined, n number infected with intestinal microsporidiosis, HIV human immunodeficiency virus, AIDS acquired immunodeficiency syndrome, ART antiretroviral therapy, NACP National AIDS Control Program, CD4 cluster of differentiation 4, OR odds ratio, CI confidence interval